EVO ICL Adoption Report, Q2 2026
EVO ICL has moved from a niche refractive option to a meaningful share of the U.S. market over the past several years. This quarterly report tracks adoption trends, patient profile, and how EVO ICL’s growth compares to adjacent procedures like LASIK and RLE. Q2 2026 continued a multi-quarter growth trend, with adoption concentrated among patients […]
State of Refractive Lens Exchange, 2026
Explore the 2026 State of Refractive Lens Exchange report, featuring U.S. trends in patient demographics, procedure volume, regional pricing, and premium intraocular lens adoption.